Neonatal hyperoxia leads to persistent alterations in NK responses to influenza a virus infection

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 308, Issue 1, 2015, Pages L76-L85

  Reilly, Emma C ^a   Martin, Kyle C ^a   Jin, Guang Bi ^a   Yee, Min ^a   O’reilly, Michael A ^a   Paige Lawrence, B ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Hematopoietic; Innate immunity; Respiratory infection

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 22; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; HEMATOPOIETIC CELL; HYPEROXIA; IMMUNE RESPONSE; INFLUENZA A; INFLUENZA VIRUS A; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; OXYGEN THERAPY; PROVOCATION TEST; ANIMAL; CELLULAR IMMUNITY; IMMUNOLOGY; INFLUENZA A VIRUS; LUNG ALVEOLUS; ORTHOMYXOVIRUS INFECTION; PATHOLOGY;

ANIMALS; ANIMALS, NEWBORN; HYPEROXIA; IMMUNITY, CELLULAR; INFLUENZA A VIRUS; INTERFERON-GAMMA; INTERLEUKINS; KILLER CELLS, NATURAL; MICE; ORTHOMYXOVIRIDAE INFECTIONS; PULMONARY ALVEOLI;

EID: 84920286780     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00233.2014     Document Type: Article

References (53)

1. Abdul-Careem MF, Mian MF, Yue G, Gillgrass A, Chenoweth MJ, Barra NG, Chew MV, Chan T, Al-Garawi AA, Jordana M, Ashkar AA. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis 206: 167–177, 2012.
2. Ahrenhoerster LS, Tate ER, Lakatos PA, Wang X, Laiosa MD. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation. Toxicol Appl Pharmacol 277: 172–182, 2014.
3. Baldridge MT, King KY, Goodell MA. Inflammatory signals regulate hematopoietic stem cells. Trends Immunol 32: 57–65, 2011.
4. Beeton ML, Maxwell NC, Davies PL, Nuttall D, McGreal E, Chakraborty M, Spiller OB, Kotecha S. Role of pulmonary infection in the development of chronic lung disease of prematurity. Eur Respir J 37: 1424–1430, 2011.
5. Ben-Ari J, Makhoul IR, Dorio RJ, Buckley S, Warburton D, Walker SM. Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats. Isr Med Assoc J 2: 365–369, 2000.
6. Bender BS, Croghan T, Zhang L, Small PA. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175: 1143–1145, 1992.
7. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189–220, 1999.
8. Buczynski BW, Yee M, Martin KC, Lawrence BP, O’Reilly MA. Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways. Am J Physiol Lung Cell Mol Physiol 305: L282–L290, 2013.
9. Buczynski BW, Yee M, Paige Lawrence B, O’Reilly MA. Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice. Am J Physiol Lung Cell Mol Physiol 302: L1078–L1087, 2012.
10. Chien YH, Tsao PN, Chou HC, Tang JR, Tsou KI. Rehospitalization of extremely-low-birth-weight infants in first 2 years of life. Early Hum Dev 66: 33–40, 2002.
11. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 106: 659–671, 2000.
12. Dauger S, Ferkdadji L, Saumon G, Vardon G, Peuchmaur M, Gaultier C, Gallego J. Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest 123: 530–538, 2003.
13. Eber E, Zach MS. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax 56: 317–323, 2001.
14. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, Trumpp A. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458: 904–908, 2009.
15. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, Zakay-Rones Z, Porgador A, Mandelboim O. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517–523, 2006.
16. Giannandrea M, Yee M, O’Reilly MA, Lawrence BP. Memory CD8_ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation. Clin Vaccine Immunol 19: 1432–1441, 2012.
17. Glasner A, Zurunic A, Meningher T, Lenac Rovis T, Tsukerman P, Bar-On Y, Yamin R, Meyers AF, Mandeboim M, Jonjic S, Mandelboim O. Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One 7: 36837, 2012.
18. Gollwitzer ES, Saglani S, Trompette A, Yadava K, Sherburn R, McCoy KD, Nicod LP, Lloyd CM, Marsland BJ. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med 20: 642–647, 2014.
19. Guo H, Topham DJ. Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection. J Virol 84: 7750–7759, 2010.
20. Guss AM, Roeselers G, Newton ILG, Young CR, Klepac-Ceraj V, Lory S, Cavanaugh CM. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J 5: 20–29, 2011.
21. Hack M, Weissman B, Breslau N, Klein N, Borawski-Clark E, Fanaroff AA. Health of very low birth weight children during their first eight years. J Pediatr 122: 887–892, 1993.
22. Hack M. Catch-up growth during childhood among very low-birth-weight children. Arch Pediatr Adolesc Med 150: 1122–1129, 1996.
23. Jacobsen SE, Ruscetti FW, Dubois CM, Keller JR. Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation. J Exp Med 175: 1759–1772, 1992.
24. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163: 1723–1729, 2001.
25. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 46: 641–643, 1999.
26. Kitchen WH, Ford GW, Doyle LW, Rickards AL, Kelly EA. Health and hospital readmissions of very-low-birth-weight and normal-birthweight children. Am J Dis Child 144: 213–218, 1990.
27. Köhler A, De Filippo K, Hasenberg M, van den Brandt C, Nye E, Hosking MP, Lane TE, Männ L, Ransohoff RM, Hauser AE, Winter O, Schraven B, Geiger H, Hogg N, Gunzer M. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood 117: 4349–4357, 2011.
28. Kroon AA, Delriccio V, Tseu I, Kavanagh BP, Post M. Mechanical ventilation-induced apoptosis in newborn rat lung is mediated via FasL/ Fas pathway. Am J Physiol Lung Cell Mol Physiol 305: L795–L804, 2013.
29. Kumar P, Thakar MS, Ouyang W, Malarkannan S. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol 6: 69–82, 2013.
30. Liang M, Wang J, Chu H, Zhu X, He H, Liu Q, Qiu J, Zhou X, Guan M, Xue Y, Chen X, Zou H. Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis. Mediators Inflamm 2013: 209179, 2013.
31. Madurga A, Mizíková I, Ruiz-Camp J, Morty RE. Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 305: L893–L905, 2013.
32. Mascaretti RS, Mataloun MM, Dolhnikoff M, Rebello CM. Lung morphometry, collagen and elastin content: changes after hyperoxic exposure in preterm rabbits. Clinics (Sao Paulo) 64: 1099–1104, 2009.
33. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun 72: 4996–5003, 2004.
34. O’Reilly MA, Marr SH, Yee M, McGrath-Morrow SA, Lawrence BP. Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus. Am J Respir Crit Care Med 177: 1103–1110, 2008.
35. O’Reilly MA, Yee M, Buczynski BW, Vitiello PF, Keng PC, Welle SL, Finkelstein JN, Dean DA, Lawrence BP. Neonatal oxygen increases sensitivity to influenza A virus infection in adult mice by suppressing epithelial expression of Ear1. Am J Pathol 181: 441–451, 2012.
36. Pedersen O, Herskind AM, Kamper J, Nielsen JP, Kristensen K. Rehospitalization for respiratory syncytial virus infection in infants with extremely low gestational age or birthweight in Denmark. Acta Paediatr 92: 240–242, 2007.
37. Peralta-Carcelen M, Jackson DS, Goran MI, Royal SA, Mayo MS, Nelson KG. Growth of adolescents who were born at extremely low birth weight without major disability. J Pediatr 136: 633–640, 2000.
38. Regal JF, Lawrence BP, Johnson AC, Lojovich SJ, O’Reilly MA. Neonatal oxygen exposure alters airway hyper-responsiveness but not the response to allergen challenge in adult mice. Pediatr Allergy Immunol 25: 180–186, 2014.
39. Saugstad OD. Oxygen and retinopathy of prematurity. J Perinatol 26: S46–S50, 2006.
40. Schmitz T, Ritter J, Mueller S, Felderhoff-Mueser U, Chew LJ, Gallo V. Cellular changes underlying hyperoxia-induced delay of white matter development. J Neurosci 31: 4327–4344, 2011.
41. Smith VC, Zupancic J, McCormick MC. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr 144: 799–803, 2004.
42. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383–390, 2011.
43. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, Kennedy KA, Poind- exter BB, Finer NN, Ehrenkranz RA, Duara S, Sanchez PJ, O’Shea TM, Goldberg RN, Van Meurs KP, Faix RG, Phelps DL, Frantz ID, Watterberg KL, Saha S, Das A, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health, and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126: 443–456, 2010.
44. Stressmann FA, Connett GJ, Goss K, Kollamparambil TG, Patel N, Payne MS, Puddy V, Legg J, Bruce KD, Rogers GB. The use of culture-independent tools to characterize bacteria in endo-tracheal aspirates from preterm infants at risk of bronchopulmonary dysplasia. J Perinat Med 38: 333–337, 2010.
45. Thébaud B, Lacaze-Masmonteil T, Watterberg K. Postnatal glucocorticoids in very preterm infants: “the good, the bad, and the ugly” Pediatrics 107: 413–415, 2001.
46. Topham DJ, Tripp RA, Doherty PC. CD8+T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 159: 5197–5200, 1997.
47. Trammell RA, Toth LA. Markers for predicting death as an outcome for mice used in infectious disease research. Comp Med 61: 492–498, 2011.
48. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20: 159–166, 2014.
49. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 117: 902–909, 2007.
50. Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 115: 997– 1003, 2005.
51. World Health Organization. Born too Soon: the Global Action Report on Preterm Birth. Geneva, Switzerland: World Health Organization, 2012.
52. Yee M, Vitiello PF, Roper JM, Staversky RJ, Wright TW, McGrath- Morrow SA, Maniscalco WM, Finkelstein JN, O’Reilly MA. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am J Physiol Lung Cell Mol Physiol 291: L1101–L1111, 2006.
53. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29: 947–957, 2008.